<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on July 28, 2020</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT04081584</url>
  </required_header>
  <id_info>
    <org_study_id>ISS</org_study_id>
    <nct_id>NCT04081584</nct_id>
  </id_info>
  <brief_title>Trans-abdominal Fetal Pulse Oximetry: Tissue Light Scattering</brief_title>
  <official_title>Trans-abdominal Fetal Pulse Oximetry: Tissue Light Scattering</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Raydiant Oximetry, Inc.</agency>
      <agency_class>Industry</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Raydiant Oximetry, Inc.</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>Yes</is_fda_regulated_device>
    <is_unapproved_device>Yes</is_unapproved_device>
    <is_us_export>No</is_us_export>
  </oversight_info>
  <brief_summary>
    <textblock>
      This study is being conducted to study light scattering properties of maternal-fetal tissue.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      The ISS customized commercial frequency domain oximeter is used to obtain light scattering
      information from the maternal abdomen for 10-20 minutes preoperatively and postoperatively in
      subjects who are having a scheduled C-section.
    </textblock>
  </detailed_description>
  <overall_status>Recruiting</overall_status>
  <start_date type="Actual">July 1, 2019</start_date>
  <completion_date type="Anticipated">June 2020</completion_date>
  <primary_completion_date type="Anticipated">June 2020</primary_completion_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Case-Only</observational_model>
    <time_perspective>Prospective</time_perspective>
  </study_design_info>
  <primary_outcome>
    <measure>Optical signal from maternal and fetal tissues</measure>
    <time_frame>Peri-operative</time_frame>
    <description>The study of light scattering through maternal/fetal tissue and through maternal tissue alone and newborn tissue alone using a commercial frequency domain oximeter and 2nd generation prototype.</description>
  </primary_outcome>
  <enrollment type="Anticipated">30</enrollment>
  <condition>Fetal Distress</condition>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>ISS Device</intervention_name>
    <description>The ISS Device (commercial and prototype) is used to measure tissue light scattering.</description>
  </intervention>
  <eligibility>
    <study_pop>
      <textblock>
        Women with singleton pregnancies of 36 weeks gestation or more undergoing c-section.
      </textblock>
    </study_pop>
    <sampling_method>Non-Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:

          1. Pregnant women with singleton pregnancies, vertex or breech presentation, scheduled
             for non-emergent cesarean delivery, including cesarean delivery for failure to
             progress with reassuring electronic fetal heart rate tracing

          2. Age greater than or equal to 18 years of age.

          3. Healthy women at equal to or greater than 36 weeks gestation undergoing non-emergency
             cesarean delivery

          4. Spinal or epidural anesthesia

        Exclusion Criteria:

          1. Emergency cesarian delivery

          2. Non-reassuring fetal heart rate tracing

          3. Less than 18 years of age

          4. Multiple gestation (twins, triplets)

          5. Presentation other than vertex or breech

          6. Less than 36 weeks of gestation

          7. General anesthesia
      </textblock>
    </criteria>
    <gender>Female</gender>
    <gender_based>Yes</gender_based>
    <gender_description>Women undergoing a C-Section</gender_description>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
  </eligibility>
  <overall_contact>
    <last_name>Laura Kemp, MA, BS</last_name>
    <phone>650-822-7762</phone>
    <email>laurakemp@raydiantoximetry.com</email>
  </overall_contact>
  <overall_contact_backup>
    <last_name>Russ Delonzor, BSM</last_name>
    <phone>650-822-7762</phone>
    <email>russdelonzor@raydiantoximetry.com</email>
  </overall_contact_backup>
  <location>
    <facility>
      <name>Tufts Medical Center</name>
      <address>
        <city>Boston</city>
        <state>Massachusetts</state>
        <zip>02111</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Vidya Iyer, MBBS,CCRP</last_name>
      <phone>617-636-0186</phone>
      <email>viyer1@tuftsmedicalcenter.org</email>
    </contact>
    <investigator>
      <last_name>Errol R Norwitz, MD, PhD, MBA</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <verification_date>September 2019</verification_date>
  <study_first_submitted>September 3, 2019</study_first_submitted>
  <study_first_submitted_qc>September 4, 2019</study_first_submitted_qc>
  <study_first_posted type="Actual">September 9, 2019</study_first_posted>
  <last_update_submitted>September 4, 2019</last_update_submitted>
  <last_update_submitted_qc>September 4, 2019</last_update_submitted_qc>
  <last_update_posted type="Actual">September 9, 2019</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Fetal Distress</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

